GeneCentric Therapeutics, Inc. Employee Directory
Biotechnology ResearchNorth Carolina, United States11-50 Employees
GeneCentric is a biotechnology research company based in Durham, North Carolina, focused on precision oncology and genomic profiling through gene expression analysis. Its core offering integrates a multimodal liquid biopsy platform that infers gene expression from circulating tumor DNA alongside DNA alterations, enabling dynamic insights into tumor biology from a single blood sample. By bridging expression data with DNA sequencing, the company aims to support biomarker discovery, therapy selection, and clinical trial enrichment, particularly for antibody-drug conjugates and other emerging cancer therapies. The business targets biopharma, diagnostic developers, and researchers seeking expression-driven companion diagnostics and new blood-based biomarkers to address gaps in cancer care. GeneCentric has a history rooted in more than a decade of gene expression research and operates in the biotechnology research industry, expanding the possibilities of what circulating tumor DNA can reveal for precision medicine.